Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Oct 31, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 41
- +3 vs. Q2 2025
- Portfolio value
- $403.3M
- +$97.4M (+31.8%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 1,252,086 | $31.9M | 7.9% | +332,086+36.1% | Added | History |
| MDTMedtronic plc | Stock | 303,441 | $28.9M | 7.2% | +79,441+35.5% | Added | History |
| MRKMerck & Co., Inc. | Stock | 322,500 | $27.1M | 6.7% | +120,500+59.7% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 581,267 | $26.2M | 6.5% | +175,267+43.2% | Added | History |
| BDXBecton Dickinson & Co | Stock | 108,829 | $20.4M | 5.1% | +10,829+11.1% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 270,963 | $17.7M | 4.4% | −14,879−5.2% | Reduced | History |
| INCYIncyte Corp | COM | 205,114 | $17.4M | 4.3% | +1,114+0.5% | Added | History |
| AMGNAmgen Inc | Stock | 61,456 | $17.3M | 4.3% | +17,456+39.7% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 147,239 | $16.3M | 4.1% | +20,239+15.9% | Added | History |
| CVSCVS Health Corp | Stock | 156,202 | $11.8M | 2.9% | −6,798−4.2% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 113,478 | $11.2M | 2.8% | +24,847+28.0% | Added | History |
| BIIBBiogen Inc. | COM | 75,475 | $10.6M | 2.6% | +24,836+49.0% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 175,852 | $9.52M | 2.4% | +53,504+43.7% | Added | History |
| CAHCardinal Health Inc | Stock | 59,536 | $9.34M | 2.3% | −6,464−9.8% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 18,444 | $8.95M | 2.2% | −7,056−27.7% | Reduced | History |
| BAXBaxter International Inc | Stock | 381,551 | $8.69M | 2.2% | +113,544+42.4% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 111,390 | $8.37M | 2.1% | +37,390+50.5% | Added | History |
| BRKRBruker Corp | COM | 250,909 | $8.15M | 2.0% | +54,939+28.0% | Added | History |
| CNCCentene Corp | Stock | 213,210 | $7.61M | 1.9% | +61,210+40.3% | Added | History |
| LHLabcorp Holdings Inc. | Stock | 25,970 | $7.45M | 1.8% | +6,486+33.3% | Added | History |
| PTCTPTC Therapeutics, Inc. | COM | 118,112 | $7.25M | 1.8% | +25,862+28.0% | Added | History |
| VTRSViatris Inc | Stock | 668,851 | $6.62M | 1.6% | +668,851 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 22,827 | $6.40M | 1.6% | +4,998+28.0% | Added | History |
| HUMHumana Inc | Stock | 23,942 | $6.23M | 1.5% | +442+1.9% | Added | History |
| ELANElanco Animal Health Inc | COM | 307,271 | $6.19M | 1.5% | +15,198+5.2% | Added | History |
| AVTRAvantor, Inc. | COM | 477,104 | $5.95M | 1.5% | +104,466+28.0% | Added | History |
| OGNOrganon & Co. | Stock | 543,711 | $5.81M | 1.4% | +543,711 | New | History |
| EWEdwards Lifesciences Corp | Stock | 72,980 | $5.68M | 1.4% | +30,980+73.8% | Added | History |
| DXCMDexcom Inc | COM | 76,821 | $5.17M | 1.3% | +26,821+53.6% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 24,327 | $4.84M | 1.2% | +7,327+43.1% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 10,883 | $4.64M | 1.2% | +2,883+36.0% | Added | History |
| ICLRIcon PLC | COM | 24,967 | $4.37M | 1.1% | +24,967 | New | History |
| SOLVSolventum Corp | Stock | 59,259 | $4.33M | 1.1% | +21,259+55.9% | Added | History |
| KURAKura Oncology, Inc. | COM | 438,415 | $3.88M | 1.0% | +438,415 | New | History |
| LNTHLantheus Holdings, Inc. | Stock | 64,403 | $3.30M | 0.8% | +14,102+28.0% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 269,542 | $3.27M | 0.8% | +59,019+28.0% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 210,814 | $3.24M | 0.8% | +210,814 | New | History |
| ELVElevance Health, Inc. | Stock | 9,603 | $3.10M | 0.8% | −9,176−48.9% | Reduced | History |
| CERTCertara, Inc. | COM | 230,565 | $2.82M | 0.7% | +230,565 | New | History |
| BNTXBioNTech SE | SPONSORED ADS | 27,732 | $2.73M | 0.7% | −9,738−26.0% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 32,009 | $2.63M | 0.7% | +7,009+28.0% | Added | History |
Sold out since Q2 2025 (3)
Positions held at the end of Q2 2025 that are gone from this filing.